Friends,
I am leaving early tomorrow morning for ASCO, but before I leave I wanted to share this link to a nice interview with Dr. Wierda and a list of pipeline targeted oral drugs here and coming for CLL.
See my blog for the list and the link; and more: bkoffman.blogspot.com
Stay strong. We are all in this together.
Brian
ASH 2017: Dr. Richard Furman on the importance of MCL-1 in CLL (chronic lymphocytic leukemia)
Dr. Wierda on the paradigm shift in CLL.
Dr. John Allan - Chronic Lymphocytic Leukemia (CLL) Patients @Undetectable Measurable Residual Disease (MRD) after Ibrutinib Plus VenetoclaxFDA Approves Zanubrutinib for Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomASH 2018: Dr. Lindsey Roeker, on real world use of venetoclax for CLL (chronic lymphocytic leukemia)
